SYNH - Syneos Health Inc Stock Price, Fair Value and News

Market Closed

SYNH Stock Price

View Fullscreen

SYNH RSI Chart

SYNH Valuation

Market Cap

4.5B

Price/Earnings (Trailing)

62.59

Price/Sales (Trailing)

0.82

EV/EBITDA

17.44

Price/Free Cashflow

27.53

SYNH Price/Sales (Trailing)

SYNH Profitability

EBT Margin

1.53%

Return on Equity

2.04%

Return on Assets

0.88%

Free Cashflow Yield

3.63%

SYNH Fundamentals

SYNH Revenue

Revenue (TTM)

5.4B

Rev. Growth (Yr)

0.39%

Rev. Growth (Qtr)

0.68%

SYNH Earnings

Earnings (TTM)

71.2M

Earnings Growth (Yr)

-98.98%

Earnings Growth (Qtr)

101.1%

Breaking Down SYNH Revenue

Last 30 days

0.6%

Last 90 days

2.2%

Trailing 12 Months

-17.0%

How does SYNH drawdown profile look like?

SYNH Financial Health

Current Ratio

1.2

Debt/Equity

0.76

Debt/Cashflow

0.1

SYNH Investor Care

Shares Dilution (1Y)

1.04%

Diluted EPS (TTM)

0.7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	5.4B	5.4B	0	0
2022	5.3B	5.4B	5.4B	5.4B
2021	4.5B	4.7B	5.0B	5.2B
2020	4.7B	4.6B	4.5B	4.4B
2019	4.5B	4.5B	4.6B	4.7B
2018	2.7B	3.5B	4.0B	4.4B
2017	1.4B	1.3B	1.5B	1.9B
2016	1.5B	1.6B	1.6B	1.6B
2015	1.2B	1.3B	1.3B	1.4B
2014	1.0B	1.1B	1.1B	1.2B
2013	0	0	0	995.1M
2012	0	0	0	868.6M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Syneos Health Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 28, 2023	brooks michael lee	back to issuer	-640,958	5.25233	-122,033	chief operating officer
Sep 28, 2023	meyers kenneth f	back to issuer	-866,321	34.639	-25,010	-
Sep 28, 2023	brooks michael lee	back to issuer	-146,630	43.00	-3,410	chief operating officer
Sep 28, 2023	tucat christian	back to issuer	-487,964	9.63518	-50,644	chief business officer
Sep 28, 2023	kralowetz donna hildebrand	back to issuer	-130,806	6.14459	-21,288	evp, chief accounting officer
Sep 28, 2023	zulueta alfonso g	back to issuer	-150,199	17.975	-8,356	-
Sep 28, 2023	olefson jonathan	back to issuer	-617,824	9.55999	-64,626	general counsel & corp secty
Sep 28, 2023	monaghan matthew e.	back to issuer	-850,411	34.5134	-24,640	-
Sep 28, 2023	wilkes david s.	back to issuer	-213,839	21.7404	-9,836	-
Sep 28, 2023	connaughton bernadette	back to issuer	-426,345	28.85	-14,778	-

Which funds bought or sold SYNH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 17, 2024	NEW MEXICO EDUCATIONAL RETIREMENT BOARD	new	-	1,700,000	1,700,000	0.06%
Apr 12, 2024	Financial Synergies Wealth Advisors, Inc.	sold off	-100	-991	-	-%
Feb 15, 2024	BARCLAYS PLC	sold off	-100	-50,000	-	-%
Feb 14, 2024	Skandinaviska Enskilda Banken AB (publ)	sold off	-100	-5,910,000	-	-%
Feb 13, 2024	PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO	sold off	-100	-11,788,000	-	-%
Feb 12, 2024	Parallel Advisors, LLC	sold off	-	-	-	-%
Feb 09, 2024	NOMURA ASSET MANAGEMENT CO LTD	sold off	-100	-48,997	-	-%
Feb 09, 2024	EverSource Wealth Advisors, LLC	sold off	-	-	-	-%
Feb 07, 2024	HUNTINGTON NATIONAL BANK	unchanged	-	-	43.00	-%
Feb 06, 2024	NATIXIS ADVISORS, L.P.	sold off	-100	-626,000	-	-%

Are Funds Buying or Selling SYNH?

Are funds buying SYNH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SYNH

No. of Funds

Unveiling Syneos Health Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jun 09, 2023	wellington management group llp	0.03%	28,720	SC 13G/A
Feb 06, 2023	wellington management group llp	9.60%	9,880,341	SC 13G/A
Jan 23, 2023	blackrock inc.	10.7%	11,030,086	SC 13G/A
Jan 10, 2023	vanguard group inc	10.05%	10,346,287	SC 13G/A
Apr 08, 2022	blackrock inc.	11.1%	11,527,780	SC 13G/A
Feb 04, 2022	wellington management group llp	9.28%	9,622,180	SC 13G/A
Feb 03, 2022	blackrock inc.	9.6%	9,910,450	SC 13G/A
Jun 09, 2021	advent international corp/ma	0%	0	SC 13D/A
Jun 09, 2021	wellington management group llp	10.28%	10,670,655	SC 13G
Jun 09, 2021	thomas h. lee advisors, llc	0%	0	SC 13D/A

Syneos Health Inc News

Latest updates

Syneos Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Revenue	0.7%	1,366	1,357	1,360	1,336	1,361	1,336	1,373	1,348	1,283	1,209	1,140	1,099	1,013	1,163	1,213	1,177	1,167	1,119	1,145	1,115	1,073
Costs and Expenses	-5.2%	1,324	1,396	1,265	1,218	1,244	1,262	1,242	1,235	1,199	1,148	1,030	1,000	978	1,114	1,130	1,108	1,109	1,092	1,066	1,075	1,042
S&GA Expenses	13.0%	183	162	138	130	139	140	149	140	145	137	121	118	108	126	174	110	111	113	110	97.00	100
EBITDA Margin	-17.3%	0.07*	0.09*	0.11*	0.12*	0.12*	0.11*	0.11*	0.11*	0.11*	0.11*	0.11*	0.10*	-	-	-	-	-	-	-	-	-
Interest Expenses	41.4%	38.00	27.00	26.00	22.00	18.00	16.00	17.00	17.00	23.00	23.00	23.00	20.00	22.00	26.00	33.00	30.00	34.00	35.00	33.00	33.00	33.00
Income Taxes	95.6%	-0.13	-3.01	-14.78	30.00	26.00	7.00	41.00	22.00	9.00	8.00	-5.01	4.00	4.00	8.00	-73.31	11.00	22.00	10.00	14.00	12.00	16.00
Earnings Before Taxes	100.9%	1.00	-75.20	41.00	117	104	53.00	117	100	51.00	47.00	87.00	67.00	8.00	42.00	18.00	70.00	34.00	-19.59	60.00	2.00	30.00
EBT Margin	-55.5%	0.02*	0.03*	0.06*	0.07*	0.07*	0.06*	0.06*	0.06*	0.05*	0.05*	0.05*	0.03*	-	-	-	-	-	-	-	-	-
Net Income	101.1%	1.00	-72.15	56.00	87.00	78.00	46.00	76.00	78.00	42.00	39.00	92.00	63.00	4.00	34.00	91.00	59.00	11.00	-30.00	46.00	-10.39	14.00
Net Income Margin	-52.0%	0.01*	0.03*	0.05*	0.05*	0.05*	0.05*	0.05*	0.05*	0.05*	0.04*	0.04*	0.04*	-	-	-	-	-	-	-	-	-
Free Cashflow	-1871.7%	-51.64	3.00	100	110	75.00	47.00	159	41.00	78.00	116	103	148	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Assets	-0.3%	8,075	8,099	8,199	8,198	8,217	8,304	8,237	8,217	8,020	7,955	8,063	7,385	7,407	7,590	7,454	7,377	7,397	7,388	7,255	7,210	7,173
Current Assets	0.3%	1,952	1,946	1,944	1,963	1,882	1,876	1,766	1,764	1,748	1,674	1,738	1,596	1,597	1,775	1,562	1,493	1,467	1,408	1,492	1,356	1,417
Cash Equivalents	-25.9%	82.00	111	112	170	106	119	106	123	261	265	272	249	343	336	164	129	107	108	156	135	174
Net PPE	-3.7%	237	246	264	256	255	240	223	205	204	203	216	196	197	196	204	201	188	176	183	175	164
Goodwill	0.1%	4,912	4,907	4,898	4,850	4,898	4,943	4,956	53.00	4,790	4,780	4,776	4,343	4,323	4,323	4,350	4,322	4,336	4,345	4,333	4,353	4,275
Liabilities	-1.3%	4,582	4,644	4,704	4,844	4,888	5,002	4,825	4,897	4,781	4,718	4,821	4,288	4,407	4,612	4,424	4,510	4,573	4,549	4,399	4,377	4,351
Current Liabilities	-3.6%	1,627	1,688	1,725	1,723	1,707	1,722	1,654	1,688	1,596	1,532	1,577	1,511	1,427	1,441	1,516	1,452	1,655	1,384	1,503	1,397	1,361
Long Term Debt	1.1%	2,642	2,612	2,611	2,752	2,812	2,906	2,776	2,894	2,864	2,863	2,902	2,465	2,653	2,832	2,550	2,680	2,535	2,786	2,737	2,776	2,835
LT Debt, Current	-	8.00	-	-	-	-	-	-	-	-	-	-	57.00	87.00	78.00	58.00	29.00	200	-	50.00	62.00	38.00
LT Debt, Non Current	1.1%	2,642	2,612	2,611	2,752	2,812	2,906	2,776	2,894	2,864	2,863	2,902	2,465	2,653	2,832	2,550	2,680	2,535	2,786	2,737	2,776	2,835
Shareholder's Equity	1.1%	3,494	3,454	3,495	3,354	3,329	3,302	3,413	3,320	3,239	3,237	3,242	3,096	3,000	2,978	3,030	2,868	2,824	2,838	2,856	2,833	2,823
Retained Earnings	0.8%	96.00	96.00	168	112	25.00	-52.63	-12.95	-88.91	-167	-165	-179	-268	-318	-322	-341	-432	-488	-493	-459	-505	-494
Additional Paid-In Capital	0.6%	3,502	3,483	3,460	3,449	3,426	3,411	3,474	3,456	3,430	3,441	3,462	3,454	3,447	3,431	3,441	3,426	3,404	3,403	3,403	3,391	3,371
Accumulated Depreciation	-	-	-	332	-	-	-	302	-	-	-	251	-	-	-	205	-	-	-	154	-	-
Shares Outstanding	0.2%	104	103	103	103	103	104	104	104	104	104	104	104	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	7,343	-	-	-	9,236	-	-	-	3,634	-	-	-	3,158	-	-	-	2,583

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Cashflow From Operations	-210.7%	-33,682	30,424	123,817	132,375	99,902	70,887	185,979	48,504	88,707	127,088	114,326	156,002	193,772	-38,607	160,548	74,419	96,820	-13,306	112,448	125,826	112,159
Share Based Compensation	7.7%	20,134	18,692	10,771	12,975	16,191	17,333	16,313	15,099	16,439	17,353	11,225	15,093	16,175	15,998	14,329	12,803	13,794	14,267	8,278	9,791	8,375
Cashflow From Investing	31.6%	-18,905	-27,622	-26,087	-28,484	-25,566	-25,497	-80,164	-228,902	-11,499	-19,781	-458,732	-8,072	-18,660	-18,620	-21,789	-28,806	-19,621	-11,445	-11,632	-101,267	-11,300
Cashflow From Financing	12939.7%	25,949	199	-149,670	-54,968	-97,947	-36,572	-122,094	35,340	-79,457	-111,366	366,441	-244,414	-173,680	229,918	-91,584	-23,970	-73,577	-26,338	-72,679	-66,983	-109,817
Buy Backs	-	-	-	-	-	-	149,961	-	21,619	29,778	44,505	8,122	16,795	-	32,029	-	1.00	6,315	26,616	-	-	10.00

SYNH Income Statement

2023-06-30

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 1,366,080	$ 1,360,739	$ 2,722,880	$ 2,696,992
Costs and operating expenses:
Direct costs (exclusive of depreciation and amortization)	1,071,363	1,034,897	2,159,912	2,079,329
Selling, general, and administrative expenses	182,523	139,040	344,040	279,206
Restructuring and other costs	10,641	8,983	95,328	24,540
Depreciation	20,777	21,241	43,950	41,820
Amortization	38,555	39,980	76,969	81,603
Total operating expenses	1,323,859	1,244,141	2,720,199	2,506,498
Income from operations	42,221	116,598	2,681	190,494
Total other expense, net:
Interest income	(1,708)	(36)	(2,236)	(39)
Interest expense	37,877	18,102	64,664	33,867
Other expense (income), net	5,391	(5,152)	14,754	(510)
Total other expense, net	41,560	12,914	77,182	33,318
Income (loss) before provision for income taxes	661	103,684	(74,501)	157,176
Income tax (benefit) expense	(132)	25,940	(3,145)	33,256
Net income (loss)	$ 793	$ 77,744	$ (71,356)	$ 123,920
Earnings (loss) per share:
Basic (USD per share)	$ 0.01	$ 0.76	$ (0.69)	$ 1.20
Diluted (USD per share)	$ 0.01	$ 0.75	$ (0.69)	$ 1.19
Weighted average common shares outstanding:
Basic (in shares)	103,679	102,596	103,502	103,130
Diluted (in shares)	104,344	103,072	103,502	103,741

SYNH Balance Sheet

2023-06-30

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash, cash equivalents, and restricted cash	$ 82,276	$ 112,004
Accounts receivable and unbilled services, net	1,699,537	1,645,162
Prepaid expenses and other current assets	169,947	186,770
Total current assets	1,951,760	1,943,936
Property and equipment, net	236,697	264,295
Operating lease right-of-use assets	95,951	172,794
Goodwill	4,911,596	4,897,518
Intangible assets, net	608,433	680,863
Deferred income tax assets	57,628	50,677
Other long-term assets	213,316	189,135
Total assets	8,075,381	8,199,218
Current liabilities:
Accounts payable	137,017	118,621
Accrued expenses	617,945	614,200
Deferred revenue	803,922	923,875
Current portion of operating lease obligations	39,502	43,984
Current portion of finance lease obligations	20,335	24,011
Current portion of long-term debt	8,437	0
Total current liabilities	1,627,158	1,724,691
Long-term debt	2,641,566	2,611,166
Operating lease long-term obligations	150,248	175,568
Finance lease long-term obligations	35,137	44,124
Deferred income tax liabilities	69,335	92,155
Other long-term liabilities	58,183	56,513
Total liabilities	4,581,627	4,704,217
Commitments and contingencies (Note 15)
Shareholders’ equity:
Preferred stock, $0.01 par value; 30,000 shares authorized, 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022	0	0
Class A common stock, $0.01 par value; 600,000 shares authorized, 103,714 and 102,911 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	1,037	1,029
Additional paid-in capital	3,502,002	3,460,152
Accumulated other comprehensive loss, net of taxes	(105,623)	(133,874)
Retained earnings	96,338	167,694
Total shareholders’ equity	3,493,754	3,495,001
Total liabilities and shareholders’ equity	$ 8,075,381	$ 8,199,218

About Syneos Health Inc

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

CEO	Ms. Michelle Keefe
WEBSITE	syneoshealth.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	28768

Syneos Health Inc Frequently Asked Questions

What is the ticker symbol for Syneos Health Inc? What does SYNH stand for in stocks?

SYNH is the stock ticker symbol of Syneos Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Syneos Health Inc (SYNH)?

As of Wed Sep 27 2023, market cap of Syneos Health Inc is 4.46 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SYNH stock?

You can check SYNH's fair value in chart for subscribers.

What is the fair value of SYNH stock?

You can check SYNH's fair value in chart for subscribers. The fair value of Syneos Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Syneos Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SYNH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Syneos Health Inc a good stock to buy?

The fair value guage provides a quick view whether SYNH is over valued or under valued. Whether Syneos Health Inc is cheap or expensive depends on the assumptions which impact Syneos Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SYNH.

What is Syneos Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Sep 27 2023, SYNH's PE ratio (Price to Earnings) is 62.59 and Price to Sales (PS) ratio is 0.82. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SYNH PE ratio will change depending on the future growth rate expectations of investors.